Hansoh Pharmaceutical Group Company financials at a glance

+ Portfolio

The revenue of Hansoh Pharmaceutical Group Company is reported as 10.02883 billion Dollars in the fiscal year 2023. The earnings were 0.46 Dollars per share in 2023, which was 0 higher than 2021. And about 2.78077 billion Dollars are reported as free cash flow in the financials of Hansoh Pharmaceutical Group Company 2023. Dividends of 0.1 Dollars per share were paid to shareholders of Hansoh Pharmaceutical Group Company stock SEHK:3692 in fiscal 2023.

HK$9.38B

Revenue

HK$0.44

Earnings Per Share

90.73%

Gross Margin %

HK$2.47B

Free Cash Flow

Revenue

9,382.41

Earnings Per Share

0.44

Gross Margin %

90.73

Free Cash Flow

2,470.48

Financials

Year	Year	TTM	2022	2021	2020	2019
Rev.	Revenue	N/A	HK$9.38B	HK$9.94B	HK$8.69B	HK$8.68B
GM %	Gross Margin %	89.40%	90.73%	91.24%	90.76%	91.51%
OM	Operating Margin	25.61%	27.79%	28.39%	31.91%	32.02%
EPS	Earnings Per Share	HK$0.43	HK$0.44	HK$0.44	HK$0.44	HK$0.45
Div.	Dividends	N/A	HK$0.10	HK$0.07	HK$0.07	HK$0.10
PR %	Payout Ratio %	0	22.73%	15.91%	15.91%	22.22%
Sha.	Shares	N/AM	5,919.95M	5,918.35M	5,918.99M	5,788.61M
OCF	Operating Cash Flow	N/A	HK$2.74B	HK$2.56B	HK$2.39B	HK$3.33B
FCF	Free Cash Flow	N/A	HK$2.47B	HK$2.10B	HK$962.83M	HK$2.75B
FCFS	Free Cash Flow Per Share	HK$0.31	HK$0.41	HK$0.35	HK$0.16	HK$0.50

Hansoh Pharmaceutical Group Company financials at a glance

Financials

Discover